You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Bulk Pharmaceutical API Sources for POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial 204099_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 409316_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 449989_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 451029_ALDRICH ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: Potassium Chloride 30 mEq in Plastic Container

Last updated: August 11, 2025


Introduction

Potassium chloride (KCl) is a widely used electrolyte supplement in clinical and hospital settings, especially in intravenous therapies to correct hypokalemia and electrolyte imbalances. The demand for high-quality bulk APIs for potassium chloride, particularly in 30 mEq formulations in plastic containers, underscores the importance of reliable sourcing. Ensuring consistent supply, regulatory compliance, and pharmaceutical-grade quality remains paramount for manufacturers, healthcare providers, and distributors.

This article provides a comprehensive overview of key API suppliers specializing in potassium chloride, focusing on those capable of providing bulk quantities suitable for 30 mEq formulations in plastic containers. It covers manufacturer profiles, sourcing considerations, regulatory credentials, and market insights relevant for stakeholders seeking dependable API partners.


Market Overview of Potassium Chloride API

Potassium chloride API is predominantly produced via chemical synthesis involving salt mineral processing, followed by purification processes such as recrystallization and filtration. The global market for potassium chloride APIs is robust, driven by the pharmaceutical and nutraceutical industries.

Major pharmaceutical-grade manufacturers focus on ensuring high purity standards (typically ≥99%), adherence to cGMP guidelines, and compliance with regulatory authorities like the FDA, EMA, and WHO. This ensures safety and efficacy in medicated formulations, including intravenous preparations.


Key API Manufacturers for Potassium Chloride

1. GP Pharmaco, Inc.

  • Overview: A leading manufacturer specializing in pharmaceutical-grade APIs, including potassium chloride. Their facilities operate under strict cGMP compliance, ensuring high quality and consistency.
  • Capabilities: Offers bulk KCl APIs in various forms, including crystalline powders suitable for formulation into 30 mEq doses in plastic containers.
  • Certifications: US FDA registration, ISO 9001, and ISO 13485.
  • Markets: North America, Europe, and Asia.

2. NutraScience Labs

  • Overview: Known for producing pharmaceutical and supplement-grade potassium chloride APIs. They emphasize high purity and reliable supply chains.
  • Capabilities: Supplies bulk potassium chloride in bulk quantities, with options for packaging suitable for hospital and pharmaceutical use.
  • Certifications: cGMP, NSF, ISO 9001.
  • Market Focus: US and global pharma markets.

3. Sichuan Kelun Pharmaceutical Co., Ltd.

  • Overview: A major Chinese manufacturer with extensive experience in the synthesis and purification of pharmaceutical APIs, including potassium chloride.
  • Capabilities: Produces high-quality KCl APIs compliant with international standards, with large manufacturing capacities.
  • Certifications: China Food and Drug Administration (CFDA), ISO 9001.
  • Market Focus: Asia, with increasing exports globally.

4. Anhui Anheng Pharmaceuticals

  • Overview: Focuses on producing potassium chloride APIs for parenteral formulations, ensuring high pharmaceutical standards.
  • Capabilities: Offers bulk API suitable for manufacturing 30 mEq dose vials or containers.
  • Certifications: GMP approved, ISO standards.

5. Vynova

  • Overview: A European producer of high-purity inorganic salts, including potassium chloride for pharmaceutical applications.
  • Capabilities: Supplies bulk APIs with purity levels suitable for IV solutions, adhering to pharmacopeial standards.
  • Certifications: GMP, ISO 9001, ISO 14001.
  • Market Focus: European and global markets.

Sourcing Considerations

Regulatory Compliance and Certification

Manufacturers must ensure APIs meet pharmacopoeial standards such as USP, EP, or BP monographs. For injectable applications, compliance with strict cGMP guidelines and regulatory approvals from FDA, EMA, or equivalent authorities are imperative. Certificates of Analysis (CoA), Certificates of Suitability (COA) for European Pharmacopoeia, or Drug Master Files (DMF) provide essential documentation.

Quality Standards and Purity

High-purity potassium chloride (≥99%) with minimal heavy metals and residual solvents is critical. Suppliers providing detailed purity testing and validated processes offer higher confidence for pharmaceutical applications.

Supply Stability and Capacity

Bulk API procurement requires assured supply chains. Leading manufacturers with scalable production capacities and proven logistics capabilities mitigate risks of shortages or delays—especially pertinent amid global disruptions.

Packaging and Storage

For 30 mEq formulations in plastic containers, APIs should be available in suitable bulk packaging—such as drums, large bottles, or sterile containers—compatible with pharmaceutical standards and ensuring maintained stability.


Market Dynamics and Regional Trends

The Asia-Pacific region hosts several large-scale API producers, notably in China and India, offering cost-effective bulk potassium chloride APIs. However, buyers often prioritize regulatory compliance, prompting increasing reliance on FDA- and EMA-approved sources or importation through verified channels.

Europe and North America primarily source APIs from manufacturers with established cGMP certifications, emphasizing quality and regulatory adherence.


Quality Assurance and Regulatory Pathways

Procurement of potassium chloride API should involve due diligence including:

  • Validation of GMP compliance
  • Review of past inspection reports
  • Verification of registration status
  • Confirming adherence to pharmacopeial standards

Compliance with import/export regulations, intellectual property rights, and environmental standards are also vital.


Conclusion

Sourcing high-quality potassium chloride API suitable for 30 mEq formulations in plastic containers demands careful evaluation of manufacturer certifications, quality standards, capacity, and regulatory compliance. Established players such as GP Pharmaco, Sichuan Kelun Pharmaceutical, and Vynova provide reliable options for pharmaceutical-grade KCl APIs tailored to domestic and international markets.

Manufacturers must prioritize regulatory adherence alongside logistical reliability, ensuring uninterrupted supply and compliance with stringent standards necessary for injectable formulations. Collaborating with reputable API manufacturers mitigates risks and supports compliance, ultimately safeguarding patient safety and product efficacy.


Key Takeaways

  • High-purity, cGMP-compliant potassium chloride APIs are essential for pharmaceutical-grade 30 mEq formulations.
  • Reputable global manufacturers include GP Pharmaco, Sichuan Kelun, Anhui Anheng, and Vynova.
  • Verify certifications such as FDA registration, ISO standards, and pharmacopeial compliance before procurement.
  • Regional sourcing trends favor Asia for cost efficiency, but stringent regulatory standards are prioritized for injectable formulations.
  • An effective supply chain encompasses quality assurance, regulatory alignment, and scalable production capacity.

FAQs

1. What are the primary regulatory considerations when sourcing potassium chloride API?
Manufacturers must ensure APIs meet pharmacopeial standards (USP, EP, BP), possess proper certifications (GMP, ISO), and have valid Certificates of Analysis. Regulatory compliance with agencies like the FDA or EMA is essential for injectable formulations.

2. How does API purity impact pharmaceutical formulations?
Higher purity levels (≥99%) reduce risks of impurities that may cause adverse reactions or compromise stability, ensuring safety and efficacy in injectable and oral potassium chloride products.

3. Are Chinese API manufacturers suitable for pharmaceutical-grade potassium chloride?
Yes, many Chinese manufacturers, including Sichuan Kelun, produce pharmaceutical-grade KCl adhering to international standards. Due diligence and verification of certifications are crucial for quality assurance.

4. What packaging options are suitable for large-scale procurement of API for injectable use?
Bulk APIs are typically supplied in drums, sterile containers, or bottles compliant with pharmaceutical standards. Packaging should ensure stability, prevent contamination, and facilitate sterile processing.

5. What factors influence current trends in API sourcing for potassium chloride?
Cost considerations, regulatory compliance, production capacity, supply chain reliability, and regional regulatory climates significantly influence sourcing decisions.


Sources

[1] Market research reports on inorganic salts and pharmaceutical APIs.
[2] Official manufacturer websites and regulatory certifications.
[3] WHO and pharmacopoeial monographs for potassium chloride.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.